1. Home
  2. CBT vs PTCT Comparison

CBT vs PTCT Comparison

Compare CBT & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBT
  • PTCT
  • Stock Information
  • Founded
  • CBT 2019
  • PTCT 1998
  • Country
  • CBT United States
  • PTCT United States
  • Employees
  • CBT N/A
  • PTCT N/A
  • Industry
  • CBT Major Chemicals
  • PTCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBT Industrials
  • PTCT Health Care
  • Exchange
  • CBT Nasdaq
  • PTCT Nasdaq
  • Market Cap
  • CBT 4.0B
  • PTCT 5.3B
  • IPO Year
  • CBT N/A
  • PTCT 2013
  • Fundamental
  • Price
  • CBT $61.48
  • PTCT $71.78
  • Analyst Decision
  • CBT Hold
  • PTCT Buy
  • Analyst Count
  • CBT 3
  • PTCT 17
  • Target Price
  • CBT $79.33
  • PTCT $73.24
  • AVG Volume (30 Days)
  • CBT 514.3K
  • PTCT 1.1M
  • Earning Date
  • CBT 11-03-2025
  • PTCT 11-04-2025
  • Dividend Yield
  • CBT 2.93%
  • PTCT N/A
  • EPS Growth
  • CBT N/A
  • PTCT N/A
  • EPS
  • CBT 6.02
  • PTCT 8.94
  • Revenue
  • CBT $3,713,000,000.00
  • PTCT $1,779,150,000.00
  • Revenue This Year
  • CBT $6.09
  • PTCT $119.02
  • Revenue Next Year
  • CBT $3.05
  • PTCT N/A
  • P/E Ratio
  • CBT $10.21
  • PTCT $8.03
  • Revenue Growth
  • CBT N/A
  • PTCT 97.54
  • 52 Week Low
  • CBT $58.99
  • PTCT $35.95
  • 52 Week High
  • CBT $117.46
  • PTCT $73.98
  • Technical
  • Relative Strength Index (RSI)
  • CBT 24.67
  • PTCT 71.08
  • Support Level
  • CBT $58.99
  • PTCT $66.10
  • Resistance Level
  • CBT $71.86
  • PTCT $73.98
  • Average True Range (ATR)
  • CBT 1.88
  • PTCT 2.58
  • MACD
  • CBT -0.81
  • PTCT 0.10
  • Stochastic Oscillator
  • CBT 17.94
  • PTCT 70.62

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: